ZVSA
Zyversa Therapeutics, Inc.
$0.21+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Larkspur Health Acquisition Corp. (LSPR) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
8 transactions (past 365 days)
| 2025-07-16 | 2025-07-11 | Cashmere Karen A. | CCO | Award | 48,100 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Wolfe Peter | CFO | Award | 60,100 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Sapirstein James | Director | Award | 11,066 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Freitag Gregory Gene | Director | Award | 11,066 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Guzman Pablo A. | CMO | Award | 48,900 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Glover Stephen C. | CEO | Award | 136,900 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Finizio Robert G | Director | Award | 11,066 | $0.00 | $0 |
| 2025-07-15 | 2025-07-11 | Park Min-Chul | Director | Award | 11,066 | $0.00 | $0 |